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A 70-year-old man visited a urological clinic with a chief complaint of pollakiuria, which was refractory
to various medications. Pelvic magnetic resonance imaging (MRI) revealed a mass 6 cm in diameter
immediately next to the left side of the bladder. The patient was referred to our hospital for further
examination. Since he had a past history of neuroﬁbroma of cauda equina, we suspected neuroﬁbromatosis
type 1. 18Fluorodeoxyglucose (FDG)-positron emission tomography (PET) demonstrated a high accumu-
lation of FDG in the pelvic mass. Under a diagnosis of neurogenic tumor, surgery was performed. As an
examination of frozen section during the surgery led us to suspect a sarcoma, the tumor was excised radically.
The pathological examination demonstrated diffuse large B cell lymphoma.
(Hinyokika Kiyo 59 : 293-296, 2013)











既往歴 : 馬尾神経線維腫，神経線維腫 1型の疑い
家族歴 : 叔父二人，神経線維腫 1型の疑い
現病歴 : 2011年 7月頃より頻尿を認め内服加療され
ていたが，改善を認めなかった．2012年 1月前医受診












Fig. 1. Pelvic MRI showed a mass lesion 6 cm in
diameter next to the left side of bladder
(arrows) and a small tumor 2 cm in diameter
(arrow head).
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Fig. 2. FDG-PET CT demonstrated a high accu-
mulation of FDG outside of the tumor
(SUV＝3.1, arrows) and in the ventral
tumor (SUV＝3.4, arrow head). Asterisk :
the area of CT-guided core needle biopsy.
画像所見 : MRI にて膀胱を左側より圧排する径 6
cm 大の腫瘤を認め，さらに腹側にも径 2 cm の腫瘤
を認めた．内部に T2WI で高信号の部位を認め内部
出血が疑われた (Fig. 1）．肉腫や内部出血を伴う末梢
神経鞘腫などが疑われた．［18F] FDG-PET CT では腫
瘤外側に standardized uptake value (SUV) max : 3.1 と
比較的高い SUV 値を認め，腹側腫瘤も FDG の集積

















Fig. 4. (A) Microscopic appearance of the tumor. The cells were very large with a round, oval, or polygonal shape
(HE, ×400). (B) Immunohistochemical staining of CD20 was positive (×400).
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Fig. 3. Macroscopic appearance of the extirpated
tumor. Asterisk : the area of CT-guided












染色にてCK陰性，S100 陰性，LCA 陽性，CD3 陰
性，CD20 陽性であり，びまん性大細胞型 B細胞リン
パ腫 (diffuse large B cell lymphoma，DLBCL) の診断と
なった (Fig. 4A，B）．また，腹側の2 cm大の腫瘤につ
いても大部分が壊死組織であったが，一部に CD20
陽性細胞を認め，DLBCL の浸潤であると思われた．
術後経過 : 手術翌日に立位が， 2日より歩行が可能




（R-CHOP 療法 : rituximab，cyclophosphamide，doxo-




































(neuroﬁbromatosis type 1，NF1) の既往を有すること
















認めた部位は腫瘍外側で FDG-PET CT にて FDG の
集積を強く認めていた部位と同部位であったのに対し
(Fig. 3 square），CT ガイド下生検を行った部位は腫瘍





DLBCL の治療方針は，年齢，血清 LDH 値，per-
formance status，病期，節外病変数などの因子を用い
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